• Skip to primary navigation
  • Skip to main content
Engineered Tissue Solutions

Engineered Tissue Solutions

  • Chronic Wound Care
    • Mirragen
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Surgical Wound Care
    • MirraSurg
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Science & Technology
  • Provider & Patient Support
    • For Providers
    • For Patients
    • Reimbursement
  • About
    • Contact Us
    • News & Events
    • Careers
    • Testimonials
  • Request Information

The Science and Outcomes of Mirragen® – a Bioactive Glass Technology

Join us for an insightful dinner discussion exploring how Mirragen, a borate-based bioactive glass fiber matrix, facilitates quality tissue formation, from well-vascularized granulation to complete re-epithelialization.


This novel technology minimizes the risk of infection relative to tissue-based products and stands as a pioneer among synthetic matrices, the fastest growing category of skin substitutes/CTPs/CAMPs. Discover how Mirragen’s versatile, easy-to-use design is transforming the approach to advanced and surgical wound care while improving patient outcomes.

Please RSVP by March 27.

We look forward to an evening of insightful conversation.

RSVP NOW
RSVP Now

Location

The Palm Charlotte
6705-B Phillips Place Court, Charlotte, NC 28210

Date & Time

Friday, April 10, 2026
5:30pm – 8:30pm ET

RSVP – The Science and Outcomes of a Bioactive Glass Technology

Loading

Learn how ETS is transforming wound care.

Access Literature
  • Request Information
  • Contact Us
  • Careers
  • LinkedIn
  • Facebook
  • Instagram
  • Disclaimer
  • Privacy
  • Terms & Conditions
  • Patents

MIRRAGEN® is a registered trademark of ETS Tech Holdings, LLC. | © ETS Wound Care